Clinical trials: Diffusion Tensor Imaging Prognosis, active
Mild Cognitive Impairment, Alzheimer Disease
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
The aim of this study is to find out whether a new image analysis technique called Cortical Disarray Measurement (CDM) could be used to help better diagnose Alzheimer's disease.
- Conditions
- Mild Cognitive Impairment, Alzheimer Disease, Dementia
- Trial name
- CONGA (NCT05579236)
- Where
- 3 sites in United Kingdom
- Volunteers
- 400 people
- Sponsor
- University Hospital Southampton NHS Foundation Trust
Diffusion Tensor Imaging Prognosis, Brain Injury, Traumatic
Description of Clinicians' Predictive Abilities Before and After a Diffusion Tensor Imaging (DTI)
With a mortality rate of over 13% in the neuro-intensive care unit, 86% of which are related to the withdrawal of active treatment, predicting a reliable neurological prognosis is of paramount importance in neuro-intensive care…
- Trial name
- Neuro-FORECAST (NCT07863414)
- Testing
- Questionnaire
- Where
- 8 sites in France
- Volunteers
- 220 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris